short CV Christian Plank, PhD 


1983-1990      Undergraduate studies in biochemistry, University of Vienna, Austria.                          Diploma thesis carried out at the Research Institute of Molecular      
                       Pathology, Vienna, Austria.

1991-1994      PhD in biochemistry, University of Vienna, Austria. Thesis carried out                        at the Research Institute of Molecular Pathology, Vienna, Austria.

1994-1997      Postdoctoral fellow. University of California, School of Pharmacy.                        Erwin Schrödinger and Max Kade fellowships.

Since 1997     Technische Universität München, Institute of Experimental Oncology 
                       and Therapy Research (since 2013 Institute of Molecular Immunology
                       – Experimental Oncology). Staff Scientist, group leader.

2003               Cofounder of OZ Biosciences SAS, Marseille, France.

2003-2004      Habilitation Thesis at Technische Universität München, Medical

Since 2009      Co-founder and managing director of Ethris GmbH, Martinsried,



1994               Austrian Academy of Sciences. Erwin Schrödinger Fellowship.

1996               Max Kade Foundation, New York and Austrian Academy of Sciences.
                       Max Kade Fellowship

1998               Young Researchers’ Award of the Federal Country of Upper Austria.

2001               Best of Biotech Business Plan Competition, Vienna. Award for one of
                       the ten best business plans

2002               Award of the Work Group Biomaterials of the German Surgical                        Society.

Since 2006      Member of the German Cluster of Excellence “Nanosystems Initiative                         Munich (NIM)” and of Center of Nanoscience (CeNS) Munich

2006-2009      Coordinator of the EU-funded project “Magselectofection”

2008               Munich Business Plan Competition and Science4Life Venture Cup.                        Award for one of the ten best business plans.

Since 2009     Deputy coordinator of the DFG Research Unit “Nanoparticle-based                        targeting of gene- and cell-based therapies” (Nanoguide/FOR 917).

2011               Go-Bio grant of the Federal Ministry of Education and Research                        together with Dr. Carsten Rudolph.